Mikan George Lawrence III's Form 4 filing
NeueHealth, Inc. (NEUE) · filed Mar 17, 2025
- Accession no.
- 0001628280-25-013316
- Filed
- Mar 17, 2025
- Trade date
- Mar 13-14, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $318.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mikan George Lawrence IIICIK 0001381037 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | Common Stock | SSaleDisposed | −35,896 | $6.74 | −$241,939.04 | 261,894 | Direct | |
| Mar 14, 2025 | Common Stock | SSaleDisposed | −12,440 | $6.13 | −$76,257.2 | 249,454 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.